Use of Intravenous Immunoglobulin Therapy at Unconventional Doses in Refractory Fulminant Systemic Lupus Erythematosus

Use of Intravenous Immunoglobulin Therapy at Unconventional Doses in Refractory Fulminant Systemic Lupus Erythematosus

The use of human intravenous immunoglobulins (IVIg) in systemic lupus erythematosus (SLE) currently relies on evidence from small case series and is mainly regarded as an off-label strategy in cases that are refractory to conventional therapies or poorly controlled with high doses of corticosteroids...

Full description

Bibliographic Details
Main Authors: Nicolò Binello, Cristina Cancelli, Stefano Passalacqua, Francesco De Vito, Gianmarco Lombardi, Giovanni Gambaro, Raffaele Manna
Format: Article
Language:English
Published: SMC MEDIA SRL 2018-08-01
Series:European Journal of Case Reports in Internal Medicine
Subjects:
Intravenous human immunoglobulins
refractory fulminant systemic lupus erythematosus
Online Access:https://www.ejcrim.com/index.php/EJCRIM/article/view/934

Internet

https://www.ejcrim.com/index.php/EJCRIM/article/view/934

Similar Items